Rational Design of CDK12/13 and BRD4 Molecular Glue Degraders
Angewandte Chemie International Edition · 15.09.2025 · 64 (38)
DOI: 10.1002/anie.202508427 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 07.08.2025. Verfasst von Zhe Zhuang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Systems Biology, ChEM-H, and Stanford Cancer Institute, Stanford School of Medicine, Stanford University, Stanford, CA, 94…. Hauptthemen laut MEDLINE: Cell Cycle Proteins, Transcription Factors, Cyclin-Dependent Kinases, Drug Design. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, ESR Marie Curie-Skłodowska fellowship, European Research Council.
Abstract (Originalsprache)
Targeted protein degradation (TPD) is an emerging therapeutic approach for the selective elimination of disease‐related proteins. While molecular glue degraders exhibit drug‐like properties, their discovery has traditionally been serendipitous and often requires post hoc rationalization. In this study, we demonstrate the rational, mechanism‐guided design of molecular glue degraders using gluing moieties. Building on established principles, by appending a chemical gluing moiety to several small molecule inhibitors, we successfully transformed them into degraders, obviating the need for a specific E3 ubiquitin ligase recruiter. Specifically, we found that incorporating a hydrophobic aromatic ring or a double bond into a cyclin‐dependent kinase 12 and 13 (CDK12/13) dual inhibitor enabled the recruitment of DNA damage‐binding protein 1 (DDB1), thereby transforming a high‐molecular‐weight bivalent CDK12 degrader into a potent monovalent CDK12/13 molecular glue degrader. We also showcase that attaching a cysteine‐reactive warhead to a bromodomain‐containing protein 4 (BRD4) inhibitor converts it into a degrader by recruiting the DDB1 and CUL4‐associated factor 16 (DCAF16) E3 ligase.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical and Systems Biology, ChEM-H, and Stanford Cancer Institute, Stanford School of Medicine, Stanford University, Stanford, CA, 94305, USA.
- Friedrich Miescher Institute for Biomedical Research, Basel, 4056, Switzerland.
- Department of Biology, University of Basel, Basel, 4001, Switzerland.
- Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
- Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, 02115, USA.
- Department of Chemistry, Stanford University, Stanford, CA, 94305, USA.
ORCID-Profile: Nathanael S Gray
Förderung
- NIH HHS
- ESR Marie Curie-Skłodowska fellowship
- European Research Council
- Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education
- European Union's H2020 Research Program
- NIH High End Instrumentation
- Stanford Chemical and Systems Biology and Stanford Cancer Institute
- Swiss National Science Foundation
Zitieren
APA
Zhuang, Z., Byun, W. S., Kozicka, Z., Donovan, K. A., Dwyer, B. G., Thornhill, A. M., Jones, H. M., Jiang, Z., Zhu, X., Fischer, E. S., Thomä, N. H., & Gray, N. S. (2025). Rational Design of CDK12/13 and BRD4 Molecular Glue Degraders. Angewandte Chemie International Edition, 64(38). https://doi.org/10.1002/anie.202508427
Vancouver
Zhuang Z, Byun WS, Kozicka Z, Donovan KA, Dwyer BG, Thornhill AM, et al. Rational Design of CDK12/13 and BRD4 Molecular Glue Degraders. Angewandte Chemie International Edition. 2025;64(38). doi:10.1002/anie.202508427
BibTeX
@article{Zhuang2025,
author = {Zhuang, Zhe and Byun, Woong Sub and Kozicka, Zuzanna and Donovan, Katherine A and Dwyer, Brendan G and Thornhill, Abby M and Jones, Hannah M and Jiang, Zixuan and Zhu, Xijun and Fischer, Eric S and Thomä, Nicolas H and Gray, Nathanael S},
title = {Rational Design of CDK12/13 and BRD4 Molecular Glue Degraders},
journal = {Angewandte Chemie International Edition},
year = {2025},
volume = {64},
number = {38},
doi = {10.1002/anie.202508427}
}
EUVIMED